Bachem: Beneficiary of the Weight Loss Boom Wants to Solve the Global [Active Ingredient Shortage] with Record Investments!

Bachem Holding AG is a leading biochemistry company specializing in peptides and oligonucleotides and an essential supplier to the global pharmaceutical industry. The portfolio ranges from research to commercial active ingredient production. Currently, Bachem is significantly benefiting from the global boom in weight loss and diabetes medications. By reliably delivering these highly complex active substances in large quantities, the company addresses the industry's most critical bottleneck – the limited production capacities – thus ensuring...